Shmuel Ben Zvi
Directeur/Bestuurslid bij BANK LEUMI LE-ISRAEL B.M.
Vermogen: - $ op 30-04-2024
Actieve functies van Shmuel Ben Zvi
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BANK LEUMI LE-ISRAEL B.M. | Directeur/Bestuurslid | 29-07-2015 | - |
| Independent Dir/Board Member | 29-07-2015 | - | |
| PROTALIX BIOTHERAPEUTICS, INC. | Directeur/Bestuurslid | 30-06-2022 | - |
| Independent Dir/Board Member | 30-06-2022 | - | |
| Shmuel (Muli) Ben Zvi Ltd. | Corporate Officer/Principal | - | - |
Loopbaan van Shmuel Ben Zvi
Eerdere bekende functies van Shmuel Ben Zvi
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| NOTABLE LABS, LTD. | Directeur/Bestuurslid | 01-09-2018 | 16-10-2023 |
| Independent Dir/Board Member | 01-09-2018 | 16-10-2023 | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01-01-2004 | 01-12-2014 |
| Israel Ministry of Defense | Corporate Officer/Principal | 01-01-2000 | 01-01-2004 |
| SOL-GEL TECHNOLOGIES LTD. | Directeur/Bestuurslid | 01-01-2018 | - |
| Independent Dir/Board Member | 01-01-2018 | - |
Opleiding van Shmuel Ben Zvi
| Tel-Aviv University | Doctorate Degree |
Statistieken
Internationaal
| Israël | 8 |
| Verenigde Staten | 2 |
Operationeel
| Director/Board Member | 4 |
| Independent Dir/Board Member | 4 |
| Corporate Officer/Principal | 3 |
Sectoraal
| Health Technology | 5 |
| Finance | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| BANK LEUMI LE-ISRAEL B.M. | Finance |
| SOL-GEL TECHNOLOGIES LTD. | Health Technology |
| PROTALIX BIOTHERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| Israel Ministry of Defense | Government |
Vascular Biogenics Ltd.
 Vascular Biogenics Ltd. BiotechnologyHealth Technology Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel. | Health Technology |
| Shmuel (Muli) Ben Zvi Ltd. |
- Beurs
- Insiders
- Shmuel Ben Zvi
- Ervaring
